621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors

Bibliographic Details
Main Authors: Nan Zhang, Kevin Conlon, Donna Bernstein, Robert Somerville, Thomas Waldmann, Rosa Nguyen, Steven Highfill, Crystal L Mackall, David Stroncek, Sabina Kaczanowska, Julia Segal, Anh Dinh, Melinda S Merchant, Rosandra N Kaplan
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797630514411077632
author Nan Zhang
Kevin Conlon
Donna Bernstein
Robert Somerville
Thomas Waldmann
Rosa Nguyen
Steven Highfill
Crystal L Mackall
David Stroncek
Sabina Kaczanowska
Julia Segal
Anh Dinh
Melinda S Merchant
Rosandra N Kaplan
author_facet Nan Zhang
Kevin Conlon
Donna Bernstein
Robert Somerville
Thomas Waldmann
Rosa Nguyen
Steven Highfill
Crystal L Mackall
David Stroncek
Sabina Kaczanowska
Julia Segal
Anh Dinh
Melinda S Merchant
Rosandra N Kaplan
author_sort Nan Zhang
collection DOAJ
first_indexed 2024-03-11T11:09:13Z
format Article
id doaj.art-25df833e7c744f0a8a4de685ddc03507
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:09:13Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-25df833e7c744f0a8a4de685ddc035072023-11-12T06:20:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0621621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumorsNan Zhang0Kevin Conlon1Donna Bernstein2Robert Somerville3Thomas Waldmann4Rosa Nguyen5Steven Highfill6Crystal L Mackall7David Stroncek8Sabina Kaczanowska9Julia Segal10Anh Dinh11Melinda S Merchant12Rosandra N Kaplan131National Institutes of Health, Bethesda, MD, USALymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USAAff81 grid.48336.3a0000000419368075National Cancer Institute Bethesda MD USA1National Institutes of Health, Bethesda, MD, USAAff237 grid.48336.3a0000000419368075Lymphoid Malignancies Branch, Center for Cancer ResearchNational Cancer Institute Bethesda MD USAPediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA1National Institutes of Health, Bethesda, MD, USAPediatrics and Medicine, Stanford University School of Medicine, Stanford, California, USA1National Institutes of Health, Bethesda, MD, USAPediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA1National Institutes of Health, Bethesda, MD, USA1National Institutes of Health, Bethesda, MD, USA3Normunity, Westport, CT, USA1National Institutes of Health, Bethesda, MD, USA
spellingShingle Nan Zhang
Kevin Conlon
Donna Bernstein
Robert Somerville
Thomas Waldmann
Rosa Nguyen
Steven Highfill
Crystal L Mackall
David Stroncek
Sabina Kaczanowska
Julia Segal
Anh Dinh
Melinda S Merchant
Rosandra N Kaplan
621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
Journal for ImmunoTherapy of Cancer
title 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
title_full 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
title_fullStr 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
title_full_unstemmed 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
title_short 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
title_sort 621 a phase i study of autologous activated nk cells rhil15 in children and young adults with refractory solid tumors
work_keys_str_mv AT nanzhang 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT kevinconlon 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT donnabernstein 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT robertsomerville 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT thomaswaldmann 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT rosanguyen 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT stevenhighfill 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT crystallmackall 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT davidstroncek 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT sabinakaczanowska 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT juliasegal 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT anhdinh 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT melindasmerchant 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors
AT rosandrankaplan 621aphaseistudyofautologousactivatednkcellsrhil15inchildrenandyoungadultswithrefractorysolidtumors